✦ LIBER ✦

Management of acquired von Willebrand's sryndrome in a patient requiring major surgery

✍ Scribed by J. M. Maddox; J. A. M. Anderson; D. Plews; C. A. Ludlam

Book ID: 108772502
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 90 KB
Volume: 11
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2005.01150.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acquired von Willebrand disease—hemostat

Acquired von Willebrand disease—hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion

✍ Rolf Dario Frank; Dagmar Kunz; Dieter Christian Wirtz 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract Acquired von Willebrand disease (aVWD) is a rare bleeding disorder that mimics congenital VWD in previously healthy individuals; it is most frequently associated with monoclonal gammopathy. Hemostatic therapy of aVWD is challenging due to the extremely shortened half‐life of endogenous

Idiopathic immune-mediated acquired von

Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: Demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor

✍ Alhumood, Salah A.; Devine, Dana V.; Lawson, Laurie; Nantel, Stephen H.; Carter, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

A case of idiopathic immune-mediated von Willebrand's disease (AvWD) associated angiodysplasia and recurrent lower gastrointestinal bleeding is reported. Coagulation parameters at presentation were activated partial thromboplastin time of 41 sec, bleeding time >15 min, factor VIII procoagulant activ

Presurgical pharmacokinetic analysis of

Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand’s disease (VWD) has limited value in dosing for surgery

✍ J. DI PAOLA; S. LETHAGEN; J. GILL; P. MANNUCCI; M. MANCO-JOHNSON; J. BERNSTEIN; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

Successful treatment with recombinant fa

Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease

✍ Philip W. Friederich; Peter C. Wever; Ernest Briët; Cornelis J. Doorenbos; Marce 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 21 KB 👁 2 views

Retrospective review of the management o

Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease

✍ Ioana C. Nitu-Whalley; Anja Griffioen; Chris Harrington; Christine A. Lee 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

## Abstract Limited data are available regarding optimal treatment with desmopressin (DDAVP) or intermediate‐purity FVIII concentrates rich in VWF (CFCs) in patients with von Willebrand disease (VWD) who undergo planned surgery. We undertook a retrospective review over 10 years (1988–1997) and iden

Clinical effectiveness of desmopressin i

Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy

✍ Castaman, G. ;Rodeghiero, F. ;Bona, E. ;Ruggeri, M. 📂 Article 📅 1989 🏛 Springer-Verlag ⚖ 342 KB